Nancy Sander, founder and president of AANMA, testified during the Food and Drug Administration (FDA)’s open public hearing segment of the March 10-11 meeting of the Joint Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee. Read the rest of this entry »
‘Featured’
Long-acting bronchodilator warnings and proposed new labeling
Published March - 11 - 2010
Public Comment Sought On Draft Guidelines for the Diagnosis and Management of Food Allergy
Published March - 8 - 2010
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is seeking public comment on a draft of Guidelines for the Diagnosis and Management of Food Allergy. The public comment period is open until May 3. Health care professionals and interested members of the public are encouraged to review the guidelines and participate in the open comment period by visiting the NIAID Food Allergy Clinical Guidelines public comment site at www.niaid.nih.gov/topics/foodAllergy/clinical/comments.htm. Read the rest of this entry »
Talk to your healthcare provider about FDA 12-hour bronchodilator warnings
Published March - 3 - 2010
Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients using asthma medications known as long-acting beta agonists (LABAs) or 12-hour bronchodilators: Advair, Foradil, Serevent and Symbicort.
This was also the message presented by allergists speaking this week at the American Academy of Allergy, Asthma and Immunology (AAAAI) annual meeting in New Orleans. Allergists are concerned that FDA’s recommendations are not consistent with Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR3) or with significant clinical practice in real-world settings. Furthermore, experts stated that FDA may have given more credence to some research that EPR3 authors considered unsupported by evidence. Read the rest of this entry »
South Dakota Is 50th State to Protect Students’ Rights to Carry and Self-Administer Asthma Medication
Published March - 2 - 2010
AANMA hails South Dakota lawmakers for making it the 50th and final state in America to establish laws protecting students’ rights to carry and self-administer their lifesaving asthma medication at school.
South Dakota’s law also enables children with anaphylaxis to carry and use auto-injectable epinephrine, making it the 45th state to protect students’ rights to carry and use anaphylaxis medication at school. Five states — Mississippi, New York, Pennsylvania, Rhode Island and Wisconsin — remain without laws allowing students to carry and self-administer anaphylaxis medication. Read the rest of this entry »
Making A Difference In Students’ Lives
Published September - 17 - 2009
Connecticut Gov. M. Jodi Rell recently met with parents, children and advocates who were instrumental in getting legislation passed in Connecticut that protects students’ rights to carry and self-administer lifesaving asthma and anaphylaxis medications at school. Read the rest of this entry »
Senator Ted Kennedy: A friend to people with asthma, allergies and COPD
Published August - 27 - 2009
Among the many tributes to Sen. Ted Kennedy, AANMA would like to acknowledge his friendship and support of our organization, especially over the past 12 years.
The Senator and his staff had a refreshingly down-to-earth approach when it came to addressing our concerns about ensuring patient access to specialty care, appropriate medications, immunotherapy and diagnostic services. They were always responsive in our efforts to make sure that all patients with these conditions have access to the care they need. Read the rest of this entry »
What’s on your mind?
Published August - 25 - 2009
There’s something new about asthma, allergies and COPD in the news nearly every day–but how much of it’s valid and how much of it is just hype?
You’ll notice that we don’t get flustered about most of the news that comes out. That’s because we have a team of medical advisors that give us the bottom line on the news for us. We go behind the news to get to the real stuff that you can use in your daily lives. Read the rest of this entry »
Students with Asthma in Connecticut and Louisiana Can Now Breathe Easier
Published July - 5 - 2009
New state legislation allows students to carry asthma and anaphylaxis medications in school
WASHINGTON, D.C., June 30, 2009—Connecticut and Louisiana have become the 48th and 49th states to enact laws allowing students to carry and self-administer life-saving asthma Read the rest of this entry »
AANMA Receives EPA Award
Published May - 14 - 2009
The U.S. Environmental Protection Agency (EPA) recently presented AANMA with its prestigious Ozone Layer Protection Award for “Extraordinary Public Communication and Outreach Supporting the Transition to Ozone-Safe Inhalers.”
The award recognizes AANMA’s patient education campaign surrounding mandatory changes being made in the metered-dose inhalers used to treat asthma, COPD and other respiratory conditions. When the international community banned the use of CFCs (ozone-depeleting chemicals used as propellants in respiratory inhalers) and U.S. officials ordered pharmaceutical manufacturers to develop new inhalers, no provision was made to educate patients and healthcare professionals about the changes. Read the rest of this entry »
Asthma Awareness Day on Capitol Hill ‘09
Published April - 14 - 2009
Breathe Freely
Make healthcare reform work for you
Wednesday, May 6, 2009
8:30-10:30 am – Breakfast Briefing
11:00 am-1:30 pm – Asthma Health Expo
Free asthma screening – Consultation with allergists – State-of-the-art lung inflammation tests
Rayburn Foyer, Rayburn House Office Building, Washington, DC Read the rest of this entry »
RSS Feed